Maintenance of sinus rhythm in patients with non-paroxysmal AF is often challenging and complex. Catheter ablation is usually superior to anti-arrhythmic drug therapy alone. However, recurrence rates are high and have remained suboptimal. Although pulmonary vein isolation (PVI) is usually effective in treating paroxysmal AF, it is not sufficient for many patients with non-paroxysmal AF, particularly those with longstanding persistent AF. A major limitation is that our understanding of mechanisms of AF is incomplete. Electroanatomical remodelling adds substantially to the complexity of AF. Recent advances in imaging and mapping technology may facilitate better understanding and mapping of AF and subsequently improve outcomes of therapy.
Maintenance of sinus rhythm in patients with non-paroxysmal AF is often challenging and complex. Catheter ablation is usually superior to anti-arrhythmic drug therapy alone. However, recurrence rates are high and have remained suboptimal. Although pulmonary vein isolation (PVI) is usually effective in treating paroxysmal AF, it is not sufficient for many patients with non-paroxysmal AF, particularly those with longstanding persistent AF. A major limitation is that our understanding of mechanisms of AF is incomplete. Electroanatomical remodelling adds substantially to the complexity of AF. Recent advances in imaging and mapping technology may facilitate better understanding and mapping of AF and subsequently improve outcomes of therapy.
The purpose of this article is to review current techniques of imaging and mapping that can be applied in the management of patients with non-paroxysmal AF with a focus on their relevance to catheter ablation. Future applications and opportunities for new knowledge will also be discussed.
Mechanisms of AF
Descriptions of AF wavefront properties are influenced by the study tools (optical mapping versus electroanatomical contact or noncontact mapping) and can explain some of the discrepancies in experimental studies and clinical observations. 1, 2 Imaging studies have shown a close association with abnormal atrial architecture and clinical AF, but a unified model relating ultrastructural remodelling to arrhythmia maintenance is less than complete. Multidisciplinary approaches incorporating imaging, basic science, computer modelling, and clinical observations are vital for addressing these knowledge gaps.
Current models of non-paroxysmal AF often focus on both triggers
and an atrial substrate able to perpetuate the arrhythmia. For patients with non-paroxysmal AF, ectopic triggers can include pulmonary vein and non-pulmonary vein triggers such as the superior vena cava, coronary sinus or crista terminalis. 3 Electroanatomical remodelling facilitates trigger formation, shortening of atrial refractory periods and the promotion of fibrosis. [4] [5] [6] Elimination of focal triggers in addition to PVI improves ablation outcomes. 7 Two competing theories on AF maintenance have been proposed and have formed the basis for various ablation techniques. The first is the multiple wavelet theory, which describes AF as self-perpetuating rhythm independent of focal discharges but rather supported by a critical mass of myocardium allowing constant formation and dispersal of wavelets. 8, 9 The second is a localised source model in which focal areas of re-entry or discharges sustain AF. These organised regions result in disorganised fibrillation due to wave-break as the impulses encounter tissue with anisotropy and conduction heterogeneity. 10 These competing mechanisms may not be mutually exclusive, particularly in patients with non-paroxysmal AF.
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Contemporary ablation strategies for non-paroxysmal AF are based on elimination of prevalent triggers (including pulmonary vein and other thoracic arrhythmogenic sites), dynamic real-time mapping of drivers of AF such as rotors and focal discharges or modification of the atrial substrate using a combination of anatomical lesion sets.
These approaches have been used alone or in combination with variable clinical outcomes. Hybrid techniques such as combined endocardial and epicardial ablation have been proposed to target the posterior wall and epicardial sources of AF. 12 Modulation of autonomic inputs through ablation of ganglionated plexi have also been considered as an adjunctive ablation strategy.
Cardiac and Thoracic Imaging
Multimodality imaging can improve management of patients with nonparoxysmal AF and assist with ablation strategies (Figure 1 ). Traditional measurements of atrial size and morphology have been supplemented with functional and structural assessments through techniques such as strain imaging and late-gadolinium enhanced cardiac magnetic resonance imaging (LGE-CMR). Nuclear imaging such as PET can measure atrial inflammation and metabolism as it pertains to AF. [14] [15] [16] In a recent pilot study, left atrial uptake of 18 F-fluorodeoxyglucose was assessed through PET-CT scans. 16 Left atrial metabolism and scarring were found to be increased in patients with greater AF burdens. Further validation of these novel techniques is needed.
Intraprocedural imaging, including intracardiac echocardiography and 3D rotational angiography, can be integrated with fluoroscopy and electroanatomical mapping to provide real-time information of challenging anatomy. 17 Current clinical applications of imaging include procedural planning, patient selection, prognostication of arrhythmia recurrence and evaluation of postoperative complications, such as pulmonary vein stenosis.
Atrial Size and Morphology
Atrial volume can be measured through a variety of non-invasive modalities including echocardiography, CT or CMR imaging with good agreement among the studies. [18] [19] [20] [21] 3D echocardiography is more accurate and reproducible than 2D echocardiography and is preferred when available ( Figure 1A) . 22 Increased atrial size is linked to poorer outcomes after ablation particularly in patients with non-paroxysmal AF. 23 Abnormal atrial morphology (increased sphericity) is a marker of advanced remodelling and also a predictor of poor outcomes including stroke ( Figure 1B) . 24, 25 
Atrial Wall Thickness
The atrium is a thin-walled, pliable structure whose size and geometry are dependent upon volume status and loading conditions. There is regional and inter-patient variability in wall thickness; pathologic and in vivo studies generally agree that the average left atrial wall thickness is between 1-4 mm and can range between 0.5-12 mm. 22, 34 
Atrial Strain
Pathological atrial remodelling can lead to chamber dilation, geometric distortion and fibrosis, which may lead to a substrate for arrhythmias including AF. These structural alterations also affect wall compliance and myocyte contractility with subsequent impairment of the normal atrial function as a conduit, reservoir and a contractile chamber. Realtime imaging with echocardiography and CMR can quantify atrial function through atrial strain assessment, which has been correlated with adverse cardiovascular outcomes include atrial arrhythmias.
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Abnormal atrial strain is associated with an increased incidence of AF as well as higher post-ablation recurrence rates in patients with paroxysmal and non-paroxysmal AF. [47] [48] [49] In a study of 65 patients with paroxysmal and persistent AF who underwent multi-modality imaging, abnormal atrial strain parameters correlated with the extent of LGE-CMR derived atrial fibrosis independent of left atrial volumes. 50 Atrial strain and the extent of fibrosis were more severe in patients with persistent rather than paroxysmal AF. These observations highlight the overlapping relationship between structural, mechanical, and electrical atrial remodelling.
Unlike traditional measures of left atrial compliance and function that rely on pulmonary vein and transmitral flow, atrial strain can be assessed while in sinus rhythm or AF. 36 Wall strain may also be a useful surrogate for assessing wall fibrosis as measured on LGE-MRI 51 and correlates with ablation outcomes.
Atrial Fibrosis
Advances in spatial and temporal resolution of CMR imaging allow for accurate imaging of the thin-walled atrial structures ( Figure   1C ). Multiple parameters including atrial wall thickness, functional left atrial parameters and fibrosis can be obtained simultaneously through CMR. 44, 52, 53 Assessment of atrial fibrosis through LGE-CMR has been performed for over a decade and has been shown to correlate spatially with both histopathological samples and endocardial voltage mapping. [54] [55] [56] However, there can be significant technical challenges that limit its broad applicability. Patients can be imaged while in AF although both irregular and rapid heart rates can limit image quality or render fibrosis assessment impossible. [57] [58] [59] Rhythm and rate control prior to imaging can be challenging in patients with non-paroxysmal AF.
Cardiac devices may be sources of significant artifact. 60 Beyond image acquisition challenges, interpretation of LGE-CMR images is variable among centres and the optimal processing technique remains to be better described. Many protocols require expert operator input to select appropriate detection thresholds,limiting the external validation of these studies. 61 Despite these current challenges, inter-and intraobserver agreement in high-volume centres remains high. was associated with arrhythmia occurrence. 72 Targeting LGE-CMR defined fibrosis may improve ablation outcomes and is the focus of the on-going DECAAF-2 trial. 73 Novel strategies incorporating LGE-MRI defined substrate into in silico atrial models to predict optimal ablation sites are also under investigation. 74 Given the challenges in technique and reproducibility and lack of prospective studies, the current role of LGE-CMR for management of patients with non-paroxysmal AF remains limited.
LGE-CMR defined fibrosis may harbour critical drivers of persistent AF. 75 Substrate-based 21 Siebermai et al. 58 Reproduced with permission from Elsevier. den Uijl et al. 24 Reproduced with permission from John Wiley and Sons.
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Step Mapping Atrial Electrical Activity AF can be triggered or sustained by focal drivers that cluster in specific regions of the left and right atrium. 82 These regions are more prevalent in patients with non-paroxysmal than paroxysmal AF likely due to advanced remodelling associated with greater AF burden.
Early strategies aimed at ablating these critical regions were based on analysis of local bipolar electrograms assessed on a point-by-point basis during AF. The various electrogram morphologies were thought to represent evidence of electrophysiological phenomenon associated with AF drivers such as high-frequency discharges, shortened refractory periods, micro-re-entry, or local conduction block. 10, 83 Such approaches include complex fractionated electrograms (CFAE),dominant frequency analysis, high Shannon entropy, or sites with activity spanning large portions of the AF cycle length. [84] [85] [86] These approaches have been the subject of multiple clinical trials with equivocal results regarding their net clinical benefit, partially due to the subjective nature of identifying such sites and the low-specificity of these sites in locating critical drivers. 87 CFAE ablation has been one of the more commonly performed mapping approaches, with various mapping systems incorporating automated detection algorithms. 83 Specific criteria for CFAEs have been proposed but most often operators will assess points manually, reducing the reproducibility of these techniques. 
CFAE-based ablation strategies in addition to

Non-invasive Mapping of AF
As opposed to point-by-point electrogram analysis, newer techniques can provide real-time mapping of electrical activity simultaneously across the atrium (Figure 2 ). These wide-field mapping techniques allows for direct visualisation of driver activity and assessment of their temporal stability. These techniques have provided key insights into the mechanism of AF and have corroborated with some observations made using optical and in silico mapping techniques.
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Invasive and non-invasive mapping techniques integrate multiple local and far-field electrocardiogram signals to represent wavefront propagation during AF. Analysis of these visualisations can help localise focal drivers of AF or the substrate necessary to sustain the arrhythmia. Panels A and B demonstrate simultaneous, bi-atrial activation maps created with a novel mapping system (Abbott). A: Left atrial rotor with counterclockwise activation (red to blue) with passive activation of the right atrium. B: Two focal sources present simultaneously, a counterclockwise right atrial rotor as well as a focal left atrial source showing centrifugal activation. C: Dispersion mapping using a PENTARAY™ (Biosense Webster) with both spatial and temporal dispersion indicating sites of interest. D: Epicardial phase mapping during AF generated by a noninvasive body mapping system (ECVUE, CardioInsight Technologies). Rotational activation is demonstrated in the posterior right upper atrium. Sources: Narayan et al.
; 102 Seitz et al. 105 Reproduced with permission from Elsevier. Haissaguerre et al. 94 Reproduced with permission from Wolters Kluwer Health.
Right atrium Left atrium
Left atrium Body surface potentials generated from atrial electrical activity can be used to create real-time epicardial activation maps ( Figure 2D ).
This approach was first used to non-invasively map AF by Guillem and colleagues using phase maps generated by 56 electrodes placed on the chest and back. 92 Additional techniques using 256-electrode vests integrated with CT imaging have been developed to provide high resolution (6 mm) 3D electroanatomical mapping. There are several limitations to non-invasive mapping that may limit its clinical applicability. Electrical activity generated by the atrium is generally low amplitude when measured on body surface electrodes, which may degrade signal quality. These systems reconstruct signals from epicardial structures only while there may be differential endocardial-epicardial activation during AF. 96 Sites identified as focal drivers could simply represent a wavefront breakthrough site from a passive endocardial structure not critical to AF propagation. Importantly, far-field signal contamination remains as a major challenge. Finally, the inter-atrial septum and LAA, which may harbour sites critical for AF, are poorly visualised with this technique. 93, 97, 98 Invasive Mapping of AF
In a prior study, a multielectrode array catheter (EnSite™, Abbott) was used to reconstruct virtual unipolar electrograms from 64 non-contact electrodes to display voltage and activation maps on a 3D anatomical map during AF. 99 Noncontact mapping (NCM) has been used to map AF activation patterns, 99,100 although some studies did not find that rotors or focal sources were prevalent or necessary for AF propagation.
NCM has been used successfully to identify conduction gaps in linear lesions sets, localise premature atrial contractures and target atrial tachycardias. 101 However, the use of NCM to ablate AF sources has not been described. log-rank p=0.026 and 15% versus 41%; log-rank p<0.001, respectively).
In separate experiments the authors used optical mapping and numerical simulations to recreate their clinical findings of increased dispersion near the vicinity of active drivers. However, a limitation of this approach is that in the absence of a panoramic map of both atria it can be difficult to identify the primary drivers and true activation patterns. These combined experimental and clinical reports suggest that regional contact mapping may be useful tool for mapping and ablating non-paroxysmal AF. However, prospective studies are needed for further validation.
Invasive mapping of AF triggers can be performed with the use of traditional multipolar catheters strategically placed to maximise diagnostic yield. 106 Catheters can be simultaneously placed in regions commonly harbouring arrhythmogenic triggers such as the superior vena cava, cristae terminals, LAA and coronary sinus. AF can then be induced with high-dose isoproterenol infusion and sites of triggers can be targeted for ablation. These triggers may be more prevalent in patients with long-standing persistent AF compared to those with persistent AF and paroxysmal AF. 107 Trigger mapping has been shown in retrospective series to be a useful strategy in patients with prior failed ablations and long-standing persistent AF.
108,109
Challenges and Future Direction approaches for persistent AF. 95 Multicentre reports and meta-analyses on the use of FIRM guided ablation have not consistently shown therapeutic benefit compared to traditional ablation strategies.
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Conclusion
Imaging and mapping technology continue to evolve providing a better understanding of anatomy, arrhythmic substrate and patterns of AF activation. These tools have been successfully implemented into ablation planning and execution at some centres. Future advances in imaging/mapping fidelity and automation could improve ease of use and facilitate real-world implementation.
The outcomes and clinical utility of ablation of predetermined targets based on anatomical landmarks with/without additional ablation of triggers, or tailored ablation of specific targets based on real-time dynamic mapping of AF mechanisms incorporating advanced imaging/ mapping systems remain to be determined and will largely depend on further advances in these technologies.
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Clinical Perspective
• Advanced mapping and imaging tools are critical components of investigation and clinical management of patients with nonparoxysmal AF.
• Used together, these tools may help facilitate tailored ablation approaches although the prospective use of these techniques compared with existing strategies must be further investigated.
• Improvements in mapping and imaging fidelity, automation and reproducibility would help increase the widespread adoption of these techniques.
